These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Amentoflavone from Selaginella tamariscina as a potent inhibitor of gut bacterial β-glucuronidase: Inhibition kinetics and molecular dynamics stimulation. Tian XG; Yan JK; Sun CP; Li JX; Ning J; Wang C; Huo XK; Zhao WY; Yu ZL; Feng L; Lv X; Ma XC Chem Biol Interact; 2021 May; 340():109453. PubMed ID: 33785314 [TBL] [Abstract][Full Text] [Related]
7. Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics. Simpson JB; Walker ME; Sekela JJ; Ivey SM; Jariwala PB; Storch CM; Kowalewski ME; Graboski AL; Lietzan AD; Walton WG; Davis KA; Cloer EW; Borlandelli V; Hsiao YC; Roberts LR; Perlman DH; Liang X; Overkleeft HS; Bhatt AP; Lu K; Redinbo MR Cell Host Microbe; 2024 Jun; 32(6):925-944.e10. PubMed ID: 38754417 [TBL] [Abstract][Full Text] [Related]
8. Three structurally and functionally distinct β-glucuronidases from the human gut microbe Pellock SJ; Walton WG; Biernat KA; Torres-Rivera D; Creekmore BC; Xu Y; Liu J; Tripathy A; Stewart LJ; Redinbo MR J Biol Chem; 2018 Nov; 293(48):18559-18573. PubMed ID: 30301767 [TBL] [Abstract][Full Text] [Related]
9. Metagenomics combined with activity-based proteomics point to gut bacterial enzymes that reactivate mycophenolate. Simpson JB; Sekela JJ; Graboski AL; Borlandelli VB; Bivins MM; Barker NK; Sorgen AA; Mordant AL; Johnson RL; Bhatt AP; Fodor AA; Herring LE; Overkleeft H; Lee JR; Redinbo MR Gut Microbes; 2022; 14(1):2107289. PubMed ID: 35953888 [TBL] [Abstract][Full Text] [Related]
10. Mouse Gut Microbiome-Encoded β-Glucuronidases Identified Using Metagenome Analysis Guided by Protein Structure. Creekmore BC; Gray JH; Walton WG; Biernat KA; Little MS; Xu Y; Liu J; Gharaibeh RZ; Redinbo MR mSystems; 2019 Aug; 4(4):. PubMed ID: 31455640 [TBL] [Abstract][Full Text] [Related]
12. An Atlas of β-Glucuronidases in the Human Intestinal Microbiome. Pollet RM; D'Agostino EH; Walton WG; Xu Y; Little MS; Biernat KA; Pellock SJ; Patterson LM; Creekmore BC; Isenberg HN; Bahethi RR; Bhatt AP; Liu J; Gharaibeh RZ; Redinbo MR Structure; 2017 Jul; 25(7):967-977.e5. PubMed ID: 28578872 [TBL] [Abstract][Full Text] [Related]
13. Regorafenib. Ettrich TJ; Seufferlein T Recent Results Cancer Res; 2014; 201():185-96. PubMed ID: 24756792 [TBL] [Abstract][Full Text] [Related]
14. Regorafenib. Ettrich TJ; Seufferlein T Recent Results Cancer Res; 2018; 211():45-56. PubMed ID: 30069758 [TBL] [Abstract][Full Text] [Related]
15. Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity. Wallace BD; Roberts AB; Pollet RM; Ingle JD; Biernat KA; Pellock SJ; Venkatesh MK; Guthrie L; O'Neal SK; Robinson SJ; Dollinger M; Figueroa E; McShane SR; Cohen RD; Jin J; Frye SV; Zamboni WC; Pepe-Ranney C; Mani S; Kelly L; Redinbo MR Chem Biol; 2015 Sep; 22(9):1238-49. PubMed ID: 26364932 [TBL] [Abstract][Full Text] [Related]
16. Regorafenib: a novel multitargeted tyrosine kinase inhibitor for colorectal cancer and gastrointestinal stromal tumors. Crona DJ; Keisler MD; Walko CM Ann Pharmacother; 2013 Dec; 47(12):1685-96. PubMed ID: 24259629 [TBL] [Abstract][Full Text] [Related]
17. Structural basis for the regulation of β-glucuronidase expression by human gut Enterobacteriaceae. Little MS; Pellock SJ; Walton WG; Tripathy A; Redinbo MR Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E152-E161. PubMed ID: 29269393 [TBL] [Abstract][Full Text] [Related]
18. Lentinan as a natural stabilizer with bioactivities for preparation of drug-drug nanosuspensions. Suo Z; Sun Q; Peng X; Zhang S; Gan N; Zhao L; Yuan N; Zhang Y; Li H Int J Biol Macromol; 2021 Aug; 184():101-108. PubMed ID: 34119545 [TBL] [Abstract][Full Text] [Related]
19. Inhibition and structure-activity relationship of dietary flavones against three Loop 1-type human gut microbial β-glucuronidases. Wang P; Wu R; Jia Y; Tang P; Wei B; Zhang Q; Wang VY; Yan R Int J Biol Macromol; 2022 Nov; 220():1532-1544. PubMed ID: 36096258 [TBL] [Abstract][Full Text] [Related]
20. Amoxapine Demonstrates Incomplete Inhibition of β-Glucuronidase Activity from Human Gut Microbiota. Yang W; Wei B; Yan R SLAS Discov; 2018 Jan; 23(1):76-83. PubMed ID: 28809607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]